Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Accounts receivable (Details)

v3.6.0.2
Summary of Significant Accounting Policies - Accounts receivable (Details)
$ in Thousands
Dec. 31, 2016
USD ($)
customer
Accounts receivable  
Allowance for doubtful accounts | $ $ 0
GlaxoSmithKline Intellectual Property Development Ltd  
Accounts receivable  
Number of customers | customer 1